Maxime Soumeillant
About Maxime Soumeillant
Maxime Soumeillant is a Principal Scientist at Bristol-Myers Squibb in New York, specializing in pharmaceutical research and development with over 8 years of experience at the company.
Current Position at Bristol-Myers Squibb
Maxime Soumeillant is currently employed as a Principal Scientist at Bristol-Myers Squibb, based in New York, New York, United States. With over 8 years of service at Bristol-Myers Squibb, Maxime contributes significantly to the efforts in pharmaceutical research and development. His role includes collaborating with cross-functional teams to advance drug candidates from discovery to clinical trials.
Education and Academic Background
Maxime Soumeillant's educational background includes a 4-year period of study from 1991 to 1995 and an additional 2 years of study from 1984 to 1986. Details on the specific institutions attended or degrees obtained are not provided. His academic training has provided a strong foundation in organic chemistry and biochemistry.
Experience in Pharmaceutical Research and Development
With extensive experience in drug discovery and development, Maxime Soumeillant has made substantial contributions to the field of pharmaceutical sciences. His work focuses on advancing drug candidates through various stages, from initial discovery to clinical trials, in collaboration with cross-functional teams. He actively participates in industry conferences and seminars, staying current with the latest developments in pharmaceutical research.
Publications in Medicinal Chemistry
Maxime Soumeillant has contributed to several peer-reviewed publications in the field of medicinal chemistry. These publications highlight his expertise and significant research efforts in medicinal chemistry, showcasing his ability to contribute valuable knowledge to the scientific community.
Mentoring and Development
In his role at Bristol-Myers Squibb, Maxime Soumeillant is involved in mentoring junior scientists and researchers. His guidance supports the professional development of newer scientists within the company, helping to cultivate the next generation of researchers in pharmaceutical sciences.